Oncolytics Biotech Inc - Calgary

5/5 β˜… based on 1 reviews

About Oncolytics Biotech Inc

Leonard Kruimer, MBA, CPA

Director

Mr. Kruimer has more than 30 years of experience in corporate finance, planning and strategy, including 20 years in senior management positions in private and publicly listed biotechnology and life science companies. Notably, Mr. Kruimer served as CFO and Executive Committee Member of Crucell from 1998 through 2011, and an integral part of the corporate sale to Johnson & Johnson for US$2.3 billion. During his tenure, he led financing activities of the company and contributed to Crucell's strategic US$450 million acquisition and integration of Swiss-based Berna Biotech. Currently, Mr. Kruimer serves as an independent director and Chairman of the Audit Committee for Zealand Pharma (Nasdaq: ZEAL), is Chairman of the Board of BioInvent AB (OMXS: BINV) and serves on the Investment Advisory Council of private equity firm, Karmijn Kapitaal Investments based in Amsterdam. Previously, he served as CFO of privately held SkylineDx, a DNA diagnostics company and as the Chairman of the Supervisory Board of privately held hemostat company ProFibrix from 2011 through its acquisition by The Medicines Company (Nasdaq: MDCO) in 2013. In 2014 Mr. Kruimer served as interim CEO of Dutch biotech company BBB Therapeutics. Prior to Crucell, Mr. Kruimer was Managing Director at TIP Europe, a GE Capital company. He was a consultant with McKinsey & Company and started his career at Price Waterhouse in New York. Mr. Kruimer holds an MBA from the Harvard Business School and is a Certified Public Accountant in New York State.

Contact Oncolytics Biotech Inc

Address :

322 11 Ave SW #804, Calgary, AB T2R, Canada

Phone : πŸ“ž +7777
Postal code : 2
Website : https://www.oncolyticsbiotech.com/
Categories :
City : R

322 11 Ave SW #804, Calgary, AB T2R, Canada

Write some of your reviews for the company Oncolytics Biotech Inc

Your reviews will be very helpful to other customers in finding and evaluating information

Rating * β˜… β˜… β˜… β˜… β˜…
Your review *

(Minimum 30 characters)

Your name *